beta
Trial Radar AI
Clinical Trial NCT07288918 for Organ Transplantation, Mobile Applications, Nursing is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

The Effect of Education on Quality of Life, Adherence to Immunosuppressive Therapy and Symptom Control in Organ Transplant Patients 108 Home-Based Medical Device

Not yet recruiting
Clinical Trial NCT07288918 is an interventional study for Organ Transplantation, Mobile Applications, Nursing and is currently not yet recruiting. Enrollment is planned to begin on 10 December 2025 and continue until the study accrues 108 participants. Led by Ondokuz Mayıs University, this study is expected to complete by 30 August 2026. The latest data from ClinicalTrials.gov was last updated on 26 December 2025.
Brief Summary
Organ transplantation is the most effective method for treating end-stage organ failure and allows patients on the verge of death to continue living. Organ transplantation involves removing all or part of an organ or tissue from the body and transplanting it to suitable patients experiencing failure. Therefore, transplants are performed to treat diseases, save lives, improve patients' quality of life, and extend thei...Show More
Official Title

The Effects of Different Educational Methods Given to Patients Undergoing Organ Transplantation on Quality of Life, Compliance With İmmunosuppressive Therapy and Symptom Control

Conditions
Organ TransplantationMobile ApplicationsNursing
Other Study IDs
  • OMU-GURKAN-001
NCT ID Number
NCT07288918
Start Date (Actual)
2025-12-10
Last Update Posted
2025-12-26
Completion Date (Estimated)
2026-08-30
Enrollment (Estimated)
108
Study Type
Interventional
PHASE
N/A
Status
Not yet recruiting
Primary Purpose
Supportive Care
Design Allocation
Randomized
Interventional Model
Parallel
Masking
Double
Arms / Interventions
Participant Group/ArmIntervention/Treatment
ExperimentalMobile applications
Mobile application installation
Transplant patients will receive standard discharge training. A mobile application created by the researcher will be installed on transplant patients' phones.
ExperimentalTeaching booklet
Providing teaching booklets
Transplant patients will receive standard discharge training. Transplant patients will be given researcher prepared instructional booklet
Active ComparatorControl
Control
Transplant patients will receive standard discharge training
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
The effect of education on quality of life in organ transplant patients
The SF-36 Quality of Life Scale will be administered before the training intervention. Most questions on the scale use Likert-type rating scales (3, 5, and 6 points), while questions four and five can be answered with yes/no. Each section of the scale is rated between 0 and 100 points. Higher scores indicate better health, or improved quality of life ("0" for poor health, "100" for good health).
Baseline, and 1, 3, and 6 months post-intervention.
The effect of education on symptom control in organ transplant patients
The Modified Transplant Symptom Occurrence and Symptom Distress Scale-59 will be administered before the training intervention. Each item on the scale corresponds to a side effect of immunosuppressive drugs, and these items have two dimensions that assess symptom occurrence and discomfort level. Symptom occurrence is scored from 1 to 5, with 1=never occurring and 5=always occurring. Symptom discomfort level is scored from 0 to 4, with 0=never causing discomfort and 4=causing extreme discomfort.
Baseline, and 1, 3, and 6 months post-intervention.
The effect of education on adherence to ımmunosuppressive therapy in organ transplant patients
The Immunosuppressant Therapy Adherence Scale in Organ Transplantation Patients will be administered before the training intervention. The scale consists of four questions, and participants can receive a score between 0 and 12. Individuals who have not forgotten their immunosuppressive treatment in the last three months are given 3 points, those with 1-20% non-adherence to immunosuppressive treatment are given 2 points, those with 21-50% non-adherence to immunosuppressive treatment are given 1 point, and those with \>50% non-adherence to immunosuppressive treatment are given 0 points.
Baseline, and 1, 3, and 6 months post-intervention.
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
  • Being over 18 years of age,
  • Having undergone a liver or kidney transplant for the first time,
  • Having been discharged at least three months ago,
  • Having access to a smartphone and internet and the ability to use them independently,

  • Having a diagnosis of a psychiatric or neurological disorder,
  • Having hearing or vision problems severe enough to impede communication,
  • Requesting to leave during the research period
Ondokuz Mayıs University logoOndokuz Mayıs University
Study Responsible Party
Rıfat GÜRKAN, Principal Investigator, Principal Investigator, Ondokuz Mayıs University
Study Central Contact
Contact: Rıfat GÜRKAN, Master of Science in Nursing, +905067154895, [email protected]
1 Study Locations in 1 Countries

Samsun

Ondokuz Mayis University, Samsun, Samsun, Turkey (Türkiye)